Skip to main content
PLOS One logoLink to PLOS One
. 2023 Nov 21;18(11):e0294885. doi: 10.1371/journal.pone.0294885

Correction: Isolation and molecular characterization of novel glucarpidases: Enzymes to improve the antibody directed enzyme pro-drug therapy for cancer treatment

Fatma B Rashidi, Alanod D Al-Qahtani, Sara S Bashraheel, Shabnam Shaabani, Matthew R Groves, Alexander Dömling, Sayed K Goda
PMCID: PMC10662713  PMID: 37988359

The Data Availability statement in [1] is incorrect as all relevant data were not provided within the article and supporting information files. With this notice, the authors provide the primary data for Figs 3, 8, 9 and 11 in S1S4 Files.

There was a spelling error in the second author’s name. The correct name is: Alanod D. Al-Qahtani. The correct citation is: Rashidi FB, Al-Qahtani AD, Bashraheel SS, Shaabani S, Groves MR, Dömling A, et al. (2018) Isolation and molecular characterization of novel glucarpidases: Enzymes to improve the antibody directed enzyme pro-drug therapy for cancer treatment. PLoS ONE 13(4): e0196254. https://doi.org/10.1371/journal.pone.0196254

In addition, the authors wish to acknowledge that the image in Fig 7B of this article [1] was reused in Fig 1A of a later article from the same group [2]. These images present the same experimental condition, isolation of wild-type Pseudomonas Putida CPG2 (Ps CPG2). Although the corresponding author referenced the original source [1] in the later article [2], he acknowledges that it should have also been indicated in the figure legend of the article [2]. The PLOS ONE Editors have assessed this issue and have no concerns about the reuse of the image from [1].

Supporting information

S1 File. Quantitative data underlying Fig 3 and 8.

(XLSX)

S2 File. Original images underlying Fig 7.

(ZIP)

S3 File. CD Spectra and settings related to Fig 9.

(ZIP)

S4 File. Original images underlying Fig 11.

(ZIP)

References

  • 1.Rashidi FB, AlQhatani AD, Bashraheel SS, Shaabani S, Groves MR, Dömling A, et al. (2018) Isolation and molecular characterization of novel glucarpidases: Enzymes to improve the antibody directed enzyme pro-drug therapy for cancer treatment. PLoS ONE 13(4): e0196254. 10.1371/journal.pone.0196254 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Al-Qahtani A. D., Bashraheel S. S., Rashidi F. B., O’Connor C. D., Romero A. R., Domling A., & Goda S. K. (2019). Production of “biobetter” variants of glucarpidase with enhanced enzyme activity. Biomedicine & Pharmacotherapy, 112, 108725. 10.1016/j.biopha.2019.108725 [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

S1 File. Quantitative data underlying Fig 3 and 8.

(XLSX)

S2 File. Original images underlying Fig 7.

(ZIP)

S3 File. CD Spectra and settings related to Fig 9.

(ZIP)

S4 File. Original images underlying Fig 11.

(ZIP)


Articles from PLOS ONE are provided here courtesy of PLOS

RESOURCES